Regional

Berrien County Medical Control Authority

Current145 dose entries37 drugs12 documentsMIeffective 2026-08-1594% machine-parsed of 145

Berrien County Medical Control Authority (MI) carries 37 drugs across 145 dose entries in its current published protocol, effective 2026-08-15.

Drugs and doses37

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	pages 105, 120, 121, 311, 312
SVT	peds	0.1 mg/kg	IV	not captured	standing	pages 105, 120, 121, 311, 312

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	2.5 mg	NEB	not captured	standing	pages 33, 313
Hyperkalemia	peds	2.5 mg	NEB	not captured	standing	pages 33, 313
Respiratory distress	adult	2.5 mg	NEB	not captured	standing	pages 15, 16, 61, 62, 83, 108, 313
Respiratory distress	peds	2.5 mg	NEB	not captured	standing	pages 15, 16, 61, 62, 83, 108, 313

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 106, 107, 119, 314, 315
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 106, 107, 119, 314, 315
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 101, 115, 314, 315
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 101, 115, 314, 315

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	325 mg	PO	not captured	standing	pages 110, 316

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 103, 117, 118, 317
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 103, 117, 118, 317
Nerve agent exposure	adult	2 mg	IV/IM	not captured	standing	pages 317, 318, 386
Nerve agent exposure	peds	0.05 mg/kg	IV/IM	not captured	standing	pages 317, 318, 386

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV	not captured	standing	pages 42, 322
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV	not captured	standing	pages 42, 322
Crush injury	adult	1 g	IV	not captured	standing	page 34
Crush injury	peds	20 mg/kg	IV	not captured	standing	page 34
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 101, 116, 322
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 101, 116, 322

Cefazolin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	page 36
Other	peds	30 mg/kg	IV	not captured	standing	page 36
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	page 36
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	page 36
Trauma / hemorrhage	peds	30 mg/kg	IV	not captured	standing	page 36
Trauma / hemorrhage	peds	30 mg/kg	IV	not captured	standing	page 36

Ceftriaxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	pages 36, 326
Other	peds	50 mg/kg	IV	not captured	standing	pages 36, 326
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	pages 36, 326
Trauma / hemorrhage	adult	2 g	IV	not captured	standing	pages 36, 326
Trauma / hemorrhage	peds	50 mg/kg	IV	not captured	standing	pages 36, 326
Trauma / hemorrhage	peds	50 mg/kg	IV	not captured	standing	pages 36, 326

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	peds	0.5 g/kg	IV/IO	not captured	standing	pages 115, 328, 329
Hypoglycemia	adult	25 g	IV	not captured	standing	pages 58, 80, 81, 88, 90, 327, 328
Hypoglycemia	peds	0.5 g/kg	IV	not captured	standing	pages 58, 80, 81, 88, 90, 327, 328
Seizure	adult	25 g	IV	not captured	standing	pages 64, 88, 327, 328
Seizure	peds	0.5 g/kg	IV	not captured	standing	pages 64, 88, 327, 328

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	10 mg	not captured	not captured	standing	pages 381, 385
Nerve agent exposure	peds	10 mg	not captured	not captured	standing	pages 381, 385
Procedural sedation	adult	5–10 mg	IV/IO	not captured	standing	pages 173, 330

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	15–20 mg	IV	not captured	standing	pages 106, 331

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	50 mg	IV/IO/IM	not captured	standing	page 16
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 16
Dystonic reaction	adult	50 mg	IV	not captured	standing	page 42
Dystonic reaction	peds	1 mg/kg	IV	not captured	standing	page 42
Nausea / vomiting	adult	12.5–25 mg	IV/IM	not captured	standing	page 10
Nausea / vomiting	peds	1 mg/kg	IV/IM	not captured	standing	page 10

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 14, 15
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 14, 15
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 103, 117, 118, 337
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 100, 115, 116, 336
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 100, 115, 116, 336
Hypotension / shock	adult	10–20 mcg	IV/IO	not captured	standing	pages 12, 13
Hypotension / shock	peds	1 mcg/kg	IV/IO	not captured	standing	pages 12, 13
Post-ROSC care	adult	10–20 mcg	IV/IO	not captured	standing	pages 112, 122, 337
Post-ROSC care	peds	1 mcg/kg	IV/IO	not captured	standing	pages 112, 122, 337
Respiratory distress	adult	0.3 mg	IM	not captured	standing	pages 62, 63, 84

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 111, 338, 339
ACS / chest pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 111, 338, 339
Mild to moderate pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 339
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	page 339
Procedural sedation	adult	50–100 mcg	IV/IO	not captured	standing	pages 173, 174, 339
Procedural sedation	peds	1 mcg/kg	IV/IO	not captured	standing	pages 173, 174, 339

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 58, 64, 81, 89, 340, 341
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 58, 64, 81, 89, 340, 341

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IM	not captured	standing	page 18
Adrenal crisis	peds	1–2 mg/kg	IV/IM	not captured	standing	page 18

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	pages 342, 343
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	pages 342, 343
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	pages 342, 343
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	pages 342, 343

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	peds	According to MI MEDIC cards	PO	not captured	standing	pages 344, 345
Mild to moderate pain	adult	400 mg	PO	not captured	standing	page 344
Mild to moderate pain	peds	According to MI MEDIC cards	PO	not captured	standing	page 344

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	pages 15, 16, 62, 63, 346
Asthma / bronchospasm	peds	500 mcg	NEB	not captured	standing	pages 15, 16, 62, 63, 346

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	4 mg/kg	IM	not captured	standing	pages 67, 348
Mild to moderate pain	adult	0.2 mg/kg	IV/IO	not captured	standing	pages 161, 348
Mild to moderate pain	adult	0.5 mg/kg	IN	not captured	standing	pages 161, 162, 348
Mild to moderate pain	peds	0.2 mg/kg	IV/IO	not captured	standing	pages 161, 348
Mild to moderate pain	peds	0.5 mg/kg	IN	not captured	standing	pages 161, 162, 348
Procedural sedation	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 173, 174, 348
Procedural sedation	peds	1.5 mg/kg	IV/IO	not captured	standing	pages 173, 174, 348

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV/IM	not captured	standing	pages 160, 349
Mild to moderate pain	peds	1 mg/kg	IV/IM	not captured	standing	pages 160, 349

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	20 mg	IO	not captured	standing	pages 189, 351
Mild to moderate pain	peds	0.5 mg/kg	IO	not captured	standing	pages 189, 351
Wide-complex tachycardia	adult	1 mg/kg	IV	not captured	standing	pages 106, 107, 120, 350
Wide-complex tachycardia	peds	1 mg/kg	IV	not captured	standing	pages 106, 107, 120, 350
VF / pulseless VT	adult	1 mg/kg	IV/IO	not captured	standing	pages 101, 115, 350
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 101, 115, 350

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV	not captured	standing	pages 63, 352
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	pages 64, 76, 353
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	pages 101, 353

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	pages 18, 354
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 18, 354
Allergic reaction	adult	125 mg	IV/IO/IM	not captured	standing	pages 17, 354
Allergic reaction	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 17, 354
Respiratory distress	adult	125 mg	IV/IO/IM	not captured	standing	pages 63, 84, 355
Respiratory distress	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 63, 84, 355

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	10 mg	IM/IN	not captured	standing	pages 67, 356
Other	adult	0.1 mg/kg	IM/IN	not captured	standing	pages 171, 357
Other	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 171, 357
Procedural sedation	adult	1–5 mg	IV/IO/IN	not captured	standing	pages 173, 174, 357
Procedural sedation	peds	0.05 mg/kg	IV/IO/IN	not captured	standing	pages 173, 174, 357
Seizure	adult	10 mg	IM	not captured	standing	pages 64, 88, 356
Seizure	adult	5 mg	IV/IO	not captured	standing	pages 64, 88, 356, 357
Seizure	adult	5 mg	IV/IO/IM/IN	not captured	standing	pages 64, 89, 356, 357
Seizure	peds	0.1 mg/kg	IM	not captured	standing	pages 64, 88, 356
Seizure	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 64, 89, 356, 357

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 358, 359
Mild to moderate pain	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 358, 359

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	2 mg	IM/IN	not captured	standing	pages 20, 21
Opioid overdose	adult	2 mg	IV	not captured	standing	page 21
Opioid overdose	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 20, 21
Opioid overdose	peds	0.1 mg/kg	IV	not captured	standing	page 21

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 110, 111, 362
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 108, 362

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	ODT	not captured	standing	page 9
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	pages 9, 10
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 9, 10
Nausea / vomiting	peds	4 mg	ODT	not captured	standing	page 9

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	small amounts	PO	not captured	standing	pages 58, 80, 90
Hypoglycemia	peds	small amounts	PO	not captured	standing	pages 58, 80, 90

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IV/IM	not captured	standing	pages 365, 385
Nerve agent exposure	peds	600 mg	IV/IM	not captured	standing	pages 365, 385

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	50 mg	PO	not captured	standing	pages 18, 368
Adrenal crisis	peds	50 mg	PO	not captured	standing	pages 18, 368
Allergic reaction	adult	50 mg	PO	not captured	standing	pages 16, 17, 368, 369
Allergic reaction	peds	50 mg	PO	not captured	standing	pages 16, 17, 368, 369
Respiratory distress	adult	50 mg	PO	not captured	standing	pages 62, 63, 84, 369
Respiratory distress	peds	50 mg	PO	not captured	standing	pages 62, 63, 84, 369

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Stridor	peds	0.5 mL	NEB	not captured	standing	page 372

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	100 mEq	IV	not captured	standing	page 34
Crush injury	peds	1 mEq/kg	IV	not captured	standing	page 34
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 101, 116
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 101, 116
Tricyclic overdose	adult	50 mEq	IV	not captured	standing	page 42
Tricyclic overdose	peds	1 mEq/kg	IV	not captured	standing	page 42

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1–2 drop	not captured	not captured	standing	pages 43, 373
Mild to moderate pain	peds	1–2 drop	not captured	not captured	standing	pages 43, 373

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 54, 374
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	pages 54, 374

Verapamil

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	5 mg	IV	not captured	standing	pages 106, 375

Cite this

Berrien County Medical Control Authority, United States EMS Protocol Census. 145 dose entries, effective 2026-08-15.

https://protoquiz.com/census/agencies/berrien-county-medical-control-authority/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.